Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical DevelopmentMagdalena Ślusarczyk, Christopher McGuigan, Monica Huerta Lopez et al.|Journal of Medicinal Chemistry|2014Cited by 151
Intensive Induction Chemotherapy With CBOP/BEP in Patients With Poor Prognosis Germ Cell TumorsJ. Christian, A. Horwich, Sophie D. Fosså et al.|Journal of Clinical Oncology|2003Cited by 66